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Editorial Comment
Agreement on the Accuracy of
Thallium Stress Testing*
K. LANCE GOULD, MD, FACC
Houston, Texas
The diagnostic accuracy of thallium stress testing. My
earlier editorial comment (I) on the accuracy of thallium
stress testing for the diagnosis of coronary artery disease,
which accompanied the study of Iskandrian et al. (2), made
three essential points:
I. The average reported sensitivity and specificity of thal-
lium exercise testing in 2,877 cumulative cases published
since 1983 (2-7), weighted for the number of cases in each
study, is 83% and 53%, respectively, associated with
approximately 17% false negative and 47% false positive
results (Table I).
2. Referral bias cannot completely explain this poor diagnostic
accuracy, which is therefore a real limitation, reducing
clinical utility of thallium stress testing as currently used.
3. This degree of error in a noninvasive diagnostic test
incurs considerable economic and personal costs related
to making the correct diagnosis by coronary arteriogra-
phy, as reported in studies (14-16) published since that
editorial comment (1).
Diamond's superb editorial in this issue of the Journal (8)
confirms the essential points of my editorial comment by
more rigorous logic. In the studies cited in his Table 5 (8),
observed sensitivity ranged from 78% to 91% and observed
specificity from 34% to 63%. With use of a sophisticated
analysis that corrected for referral bias, Diamond calculated
a "corrected" sensitivity and specificity from the observed
values. After accounting for referral bias, his average "cor-
rected" sensitivity was 67.5% and average "corrected"
specificity 75%.
My editorial comment (1) carefully concluded that referral
bias could not completely explain the reported poor sensitivity
and specificity of thallium stress testing. Depending on whether
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images were aggressively or conservatively interpreted as
abnormal. I estimated that the currently reported average 83%
sensitivity and 53% specificity were approximately equivalent
to 65% sensitivity and 65% specificity if images were currently
interpreted by approximately the same criteria as in the years
before 1983, without correction for referral bias. Diamond's
estimates (8) with a correction for referral bias were an average
of 67.5% "corrected" sensitivity and 75% "corrected" speci-
ficity, compared with my estimates of 65% and 65%, respec-
tively, without correction for referral bias. Therefore, his
results are remarkably consistent with mine and verify the poor
diagnostic accuracy of thallium stress testing regardless of how
the analysis is done.
Definitions and terminology of diagnostic accuracy. There
are minor differences in our approaches that Diamond (8)
criticizes. He eloquently defends referral bias as a concept.
I did not claim otherwise, but only that referral bias cannot
be invoked to completely explain the poor diagnostic result
confirmed by his own analysis. With regard to the defini-
tion of sensitivity and specificity that Diamond criticizes,
it is clear that Iskandrian and I understand the term. This
criticism merely establishes Diamond's expertise and the
"rigor" of his analysis, all of which I accept.
However, there is a valid semantic difference here because
we have no accepted term for a hypothetical sensitivity and
specificity, for a hypothetical group affected by a hypothetical
referral bias, none of which can be empirically verified. Which
terms should we use: "true," "measured," "corrected for
referral bias" or "apparent" sensitivities and specificities-all
of which mayor may not be invariant, according to Diamond's
claims, depending on how they are defined? Diamond's use of
positive and negative predicted accuracy may avoid the seman-
tic issue. but his calculations also confirm the poor diagnostic
accuracy of thallium stress testing. It is important that our
minor semantic differences do not detract from our remarkable
agreement, namely, that the diagnostic accuracy of thallium
stress testing, as currently practiced, is not satisfactory in
modern cardiovascular medicine.
Two other statements in Diamond's analysis (8) are
worthy of emphasis. First, he confirms the error in using
patients not undergoing catheterization as normal subjects,
which I also criticized. Second, he emphasizes that single
photon emission computed tomographic (SPEeT) thallium
testing has not yet been demonstrated to have greater
accuracy than planar imaging, a point of view for which I am
often accused of bias.
The personal and economic costs of initial misdiagnosis by
thallium stress testing. These costs may be substantial,
including unnecessary coronary arteriography in patients
with a false positive test, as recently analyzed (1,14-16). The
price of not detecting disease by noninvasive testing may
also be substantial in terms of both lives and medical
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Table 1. Comparison of Clinical Imaging Trials for Patient Management
Accuracy (%)
No. of
Diagnostic Test Sn Sp Patients Study
Diagnosis of coronary artery 82 62 461 Iskandrian et al. (2)
disease by thallium 83 47 197 Van Train et al. (3)
stress testing since 1983 85 52 1.096 Ranhosky et al. (4)
95 71 210 DePasquale et al. (5)
76 49 832 Schwartz et al. (6)
94 52 81 Bungo and Leland (7)
Average weighted for no. of cases 83 53
"Corrected.. 75 67.5 Diamond (8)
"Corrected.. 65 65 Gould (I)
Diagnosis of coronary artery 95 100 50 Gould et al. (91
stenosis with use of rubidium-82 94 95 193 Derner et al. (I OJ
with a fast PET scanner 97 100 32 Schelbert et al. (11)
or nitrogen-13 ammonia 97 100 49 Yonekura et al. (12)
98 93 146 Williams et al. (13)
Numbers in parentheses are reference numbers. PET = positron emission tomographic.
expense. These hidden costs need to be considered when
analyzing the cost-effectiveness of positron emission tomog-
raphy (PET) with its greater diagnostic accuracy (9-13).
In my personal practice, I have seen several cases of sudden
death or myocardial infarction, or both, within several weeks
or months after a normal thallium scan. In addition, I com-
monly see normal thallium studies in patients who are identi-
fied by PET to have severe coronary artery disease requiring
mechanical intervention, or moderate disease requiring vigor-
ous cholesterol lowering that would not otherwise be insti-
tuted. As a practicing cardiologist with a reasonably intense
interest in my patients' well-being, I find it untenable to say to
them 50% to 60% of the time, '"sorry, my noninvasive test
showing that you have coronary artery disease (or not) was
wrong." After personally performing over 1,000 clinical PET
studies and making therapeutic decisions based on them, I
don't need to say that very often anymore.
It is gratifying to see this series of concurring reports by
Iskandrian, Diamond and myself, which finally clearly states
the questions and available data to allow cardiovascular
practitioners to make their own judgments on the accuracy
of thallium exercise testing.
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